Madrigal Pharmaceuticals Inc (MDGL) — Working Capital to Net Assets Ratio
Madrigal Pharmaceuticals Inc (MDGL) has a Working Capital to Net Assets ratio of 155.2% as of December 2025. Working capital of $935.48 Million (current assets of $1.25 Billion minus current liabilities of $310.29 Million) is measured against net assets of $602.69 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See MDGL defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Madrigal Pharmaceuticals Inc Working Capital to Net Assets (2003–2025)
This chart shows how Madrigal Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2003 to 2025. As of December 2025, the ratio stands at 155.2%, reflecting working capital of $935.48 Million against net assets of $602.69 Million USD. For the complete balance sheet picture, see MDGL current and non-current assets.
Annual Working Capital to Net Assets for Madrigal Pharmaceuticals Inc (2003–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Madrigal Pharmaceuticals Inc from 2003 to 2025, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Madrigal Pharmaceuticals Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 155.2% | $935.48 Million | $602.69 Million | $1.25 Billion | $310.29 Million | ▲ +40.7 pp |
| 2024 | 114.5% | $863.65 Million | $754.38 Million | $1.03 Billion | $169.28 Million | ▼ -13.5 pp |
| 2023 | 128.0% | $518.73 Million | $405.33 Million | $637.28 Million | $118.55 Million | ▲ +3.6 pp |
| 2022 | 124.4% | $245.47 Million | $197.39 Million | $361.37 Million | $115.89 Million | ▲ +25.0 pp |
| 2021 | 99.4% | $194.85 Million | $196.11 Million | $271.68 Million | $76.84 Million | ▼ -0.1 pp |
| 2020 | 99.4% | $238.61 Million | $239.97 Million | $285.16 Million | $46.56 Million | ▼ -0.2 pp |
| 2019 | 99.6% | $415.07 Million | $416.56 Million | $440.20 Million | $25.13 Million | ▼ -0.3 pp |
| 2018 | 100.0% | $476.76 Million | $476.98 Million | $485.20 Million | $8.44 Million | ▲ +0.1 pp |
| 2017 | 99.8% | $181.96 Million | $182.26 Million | $192.01 Million | $10.05 Million | ▼ -0.2 pp |
| 2016 | 100.0% | $36.41 Million | $36.41 Million | $41.21 Million | $4.80 Million | ▲ +197.0 pp |
| 2015 | -97.0% | $-48.91 Million | $50.41 Million | $363.58K | $49.28 Million | ▼ -202.1 pp |
| 2014 | 105.1% | $68.46 Million | $65.14 Million | $99.35 Million | $30.89 Million | ▼ -17.2 pp |
| 2013 | 122.3% | $60.03 Million | $49.09 Million | $92.24 Million | $32.21 Million | ▲ +18.5 pp |
| 2012 | 103.8% | $77.90 Million | $75.07 Million | $101.39 Million | $23.49 Million | ▼ -66.4 pp |
| 2011 | 170.2% | $25.14 Million | $14.77 Million | $40.29 Million | $15.15 Million | ▲ +22.0 pp |
| 2010 | 148.1% | $34.78 Million | $23.48 Million | $51.52 Million | $16.74 Million | ▲ +35.3 pp |
| 2009 | 112.8% | $28.11 Million | $24.91 Million | $44.57 Million | $16.47 Million | ▲ +211.3 pp |
| 2008 | -98.5% | $57.90 Million | $-58.79 Million | $91.22 Million | $33.32 Million | ▼ -485.0 pp |
| 2007 | 386.5% | $96.22 Million | $24.90 Million | $117.00 Million | $20.77 Million | ▲ +2451.8 pp |
| 2006 | -2065.3% | $36.08 Million | $-1.75 Million | $47.63 Million | $11.55 Million | ▼ -2157.7 pp |
| 2005 | 92.4% | $48.48 Million | $52.48 Million | $62.95 Million | $14.47 Million | ▼ -3.5 pp |
| 2004 | 95.9% | $113.15 Million | $117.96 Million | $126.02 Million | $12.88 Million | ▲ +0.2 pp |
| 2003 | 95.7% | $73.56 Million | $76.89 Million | $77.06 Million | $3.50 Million | — |